Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Most

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Nature Medicine|August 2, 2003
Sealing the leak, healing the heartPatrick Most, Walter J Koch
Future Cardiology|October 7, 2009
S100A1: a calcium-modulating inotropic prototype for future clinical heart failure therapyPatrick Most, Walter J Koch
FEBS Letters|February 4, 2014
Induction of microRNA-138 by pro-inflammatory cytokines causes endothelial cell dysfunctionAnagha Sen, Patrick Most, Karsten Peppel
Cardiovascular Research|October 24, 2002
Conditional AC type VI expression in the heart: relevant insights into function of inducible target gene expressionPatrick Most, Andrew Remppis, Hugo A Katus
Expert Opinion on Biological Therapy|November 24, 2007
Recent findings into the potential of gene therapy to reverse heart failureSven T Pleger, Patrick Most, Walter J Koch
Cardiovascular Research|May 29, 2007
S100 proteins: a missing piece in the puzzle of heart failure?Sven T Pleger, Patrick Most, Hugo A Katus
Expert Opinion on Therapeutic Targets|April 19, 2024
S100A1: a promising therapeutic target for heart failureDorothea Noll, Dorothea Kehr, Patrick Most, et al.
Pharmacogenomics|April 1, 2011
Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatmentPhilip W Raake, Walter J Koch, Patrick Most
Journal of Biomedicine & Biotechnology|April 7, 2010
S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial functionMirko Völkers, David Rohde, Chelain Goodman, et al.
Journal of Cardiac Failure|July 3, 2007
Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapySven T Pleger, Matthieu Boucher, Patrick Most, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Nature Medicine|August 2, 2003
Sealing the leak, healing the heartPatrick Most, Walter J Koch
Future Cardiology|October 7, 2009
S100A1: a calcium-modulating inotropic prototype for future clinical heart failure therapyPatrick Most, Walter J Koch
FEBS Letters|February 4, 2014
Induction of microRNA-138 by pro-inflammatory cytokines causes endothelial cell dysfunctionAnagha Sen, Patrick Most, Karsten Peppel
Cardiovascular Research|October 24, 2002
Conditional AC type VI expression in the heart: relevant insights into function of inducible target gene expressionPatrick Most, Andrew Remppis, Hugo A Katus
Expert Opinion on Biological Therapy|November 24, 2007
Recent findings into the potential of gene therapy to reverse heart failureSven T Pleger, Patrick Most, Walter J Koch
Cardiovascular Research|May 29, 2007
S100 proteins: a missing piece in the puzzle of heart failure?Sven T Pleger, Patrick Most, Hugo A Katus
Expert Opinion on Therapeutic Targets|April 19, 2024
S100A1: a promising therapeutic target for heart failureDorothea Noll, Dorothea Kehr, Patrick Most, et al.
Pharmacogenomics|April 1, 2011
Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatmentPhilip W Raake, Walter J Koch, Patrick Most
Journal of Biomedicine & Biotechnology|April 7, 2010
S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial functionMirko Völkers, David Rohde, Chelain Goodman, et al.
Journal of Cardiac Failure|July 3, 2007
Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapySven T Pleger, Matthieu Boucher, Patrick Most, et al.
Pageof 11